Likewise, a randomized placebo-controlled trial was conducted to investigate the possible action of astaxanthin administration on lipid peroxidation, adiponectin levels, glycemic control, anthropometric indices, and insulin sensitivity in subjects with T2DM, which is a common cause and driver of kidney damage. Here, ADIPOQ is linked to Nephropathy.